{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T11:32:38Z","timestamp":1766748758710},"reference-count":67,"publisher":"Media Sphere Publishing Group","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. nevrol. psikhiatr. im. S.S. Korsakova"],"published-print":{"date-parts":[[2019]]},"DOI":"10.17116\/jnevro2019119041115","type":"journal-article","created":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T05:32:35Z","timestamp":1559539955000},"page":"115","source":"Crossref","is-referenced-by-count":19,"title":["Combined administration of mexidol with known medicines"],"prefix":"10.17116","volume":"119","author":[{"given":"T. A.","family":"Voronina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. A.","family":"Ivanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6743","reference":[{"key":"key-10.17116\/jnevro2019119041115-1","unstructured":"Mexidol for injection - official* instructions for use. Accessed February 20, 2019. (In Russ.) https:\/\/medi.ru\/instrukciya\/meksidol-dlya-inektsij_2601\/"},{"key":"key-10.17116\/jnevro2019119041115-2","unstructured":"Prikaz Ministerstva zdravoohraneniya Rossijskoj Federacii ot 29.12.12 g. #1740n 'Ob utverzhdenii standarta specializirovannoj medicinskoj pomoshchi pri infarkte mozga'. Accessed February 20, 2019. (In Russ.) https:\/\/www.rosminzdrav.ru\/documents\/8970"},{"key":"key-10.17116\/jnevro2019119041115-3","unstructured":"Registr lekarstvennyh sredstv Rossii. Accessed February 20, 2019. (In Russ) https:\/\/www.rlsnet.ru\/tn_index_id_679.htm"},{"key":"key-10.17116\/jnevro2019119041115-4","unstructured":"Spravochnik lekarstvennyh sredstv VIDAL. Accessed February 20, 2019. (In Russ.) https:\/\/www.vidal.ru\/drugs\/mexidol__39928"},{"key":"key-10.17116\/jnevro2019119041115-5","unstructured":"Voronina TA. Novye napravleniya poiska nootropnyh preparatov (problemnaya stat'ya). Vestnik RAMN. 1998;(1):16-21. (In Russ.)"},{"key":"key-10.17116\/jnevro2019119041115-6","unstructured":"Voronina TA. Antioxidant Mexidol. The basic neuropsychotropic effects and mechanism of action. Psychopharmacology and Biological Narcology. 2001;1(1):2-12. (In Russ.)"},{"key":"key-10.17116\/jnevro2019119041115-7","unstructured":"Voronina TA. Mexidol: main neuropsychotropic effects and mechanisms of action. Farmateka. 2009;180(6):1-4. (In Russ.)"},{"key":"key-10.17116\/jnevro2019119041115-8","unstructured":"Dyumaev KM, Voronina TA, Smirnov LD. Antioksidanty v profilaktike i terapii patologij CNS. M.: Izd-vo In-ta biomed. himii. 1995. (In Russ.)"},{"key":"key-10.17116\/jnevro2019119041115-9","unstructured":"Shchul'kin AV. Effect of mexidol on the development of the phenomenon of the neuronal excitotoxicity in vitro. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2012;112(2):35-39. (In Russ.)"},{"key":"key-10.17116\/jnevro2019119041115-10","doi-asserted-by":"crossref","unstructured":"Luk'yanova LD, Atabaeva RE, Shepeleva SYu. Antihypoxic effects of some 3-hydroxypyridine derivatives in isolated rat myocardium. Bulletin of Experimental Biology and Medicine. 1993;115(3):259-260. (In Russ.)","DOI":"10.1007\/BF00850908"},{"key":"key-10.17116\/jnevro2019119041115-11","unstructured":"Luk'yanova LD. Sovremennye problemy gipoksii. Vestnik RAMN. 2000;9:3-12. (In Russ.)"},{"key":"key-10.17116\/jnevro2019119041115-12","unstructured":"Yasnecov VV. Vliyanie nekotoryh nejrotropnyh veshchestv na dyhanie mitohondrij kletok golovnogo mozga krys. Vestnik Volgogradskogo Gosudarstvennogo Medicinskogo Universiteta. 2009;2:72-73. (In Russ.)"},{"key":"key-10.17116\/jnevro2019119041115-13","unstructured":"Yasnecov VV. Protective effect of 3-hydroxy-pyridine derivatives in extreme conditions. Aviakosmicheskaya i Ekologicheskaya Meditsina. 2007;41(6):5-12. (In Russ)"},{"key":"key-10.17116\/jnevro2019119041115-14","doi-asserted-by":"publisher","DOI":"10.25557\/0031-2991.2018.04.36-40"},{"key":"key-10.17116\/jnevro2019119041115-15","unstructured":"Voronina TA. Mexidol: the spectrum of pharmacological effects. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2012;112(12):86-90. (In Russ.)"},{"key":"key-10.17116\/jnevro2019119041115-16","unstructured":"Voronina TA. Present-day problems in experimental psychopharmacology of nootropic drugs. Neuropharmacology. 1992;2:51-108."},{"key":"key-10.17116\/jnevro2019119041115-17","unstructured":"Sariev AK, Zherdev VP, Dvoryaninov AA, Voronina TA, Smirnov LD. Farmakokinetika vodorastvorimogo antioksidanta iz klassa 3-oksipiridina. Bulletin of Experimental Biology and Medicine. 1986;3:325-327. (In Russ.)"},{"key":"key-10.17116\/jnevro2019119041115-18","doi-asserted-by":"crossref","unstructured":"Shchul'kin AV, Yakusheva EN, Chernykh IV. The distribution of mexidol in the rat's brain and its subcellular fractions. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2014;114(8):70-73. (In Russ.)","DOI":"10.17116\/jnevro201411411240-43"},{"key":"key-10.17116\/jnevro2019119041115-19","unstructured":"Usanova AA, Inchina VI, Zor'kina AV. Citoprotektory v korrekcii sochetannyh metabolicheskih narushenij. Saransk: Vektor-print; 2009. (In Russ.)"},{"key":"key-10.17116\/jnevro2019119041115-20","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-017-0456-z"},{"key":"key-10.17116\/jnevro2019119041115-21","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro20181186163-67"},{"key":"key-10.17116\/jnevro2019119041115-22","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro2017117101"},{"key":"key-10.17116\/jnevro2019119041115-23","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00770.2003"},{"key":"key-10.17116\/jnevro2019119041115-24","unstructured":"Kuznecov YuV, Matyushin IA, Smirnov LD, Yasnecov VikV. Issledovanie antiokislitel'noj aktivnosti novyh analogov ehtilmetilgidroksipiridina sukcinata i proizvodnyh gidroksipirididobenzimidazola. Vestnik Novyh Medicinskih Tekhnologij. 2006;13(3):9-10. (In Russ.)"},{"key":"key-10.17116\/jnevro2019119041115-25","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-5846(03)00037-X"},{"key":"key-10.17116\/jnevro2019119041115-26","doi-asserted-by":"crossref","unstructured":"Voronina TA, Kutepova OA. Experimentally established geropsychotropic properties of 3-hydroxypyridine antioxidant. Drug Development Research. 1988;14:353-358.","DOI":"10.1002\/ddr.430140329"},{"key":"key-10.17116\/jnevro2019119041115-27","unstructured":"Nootropic drugs in Alzheimer disease treatment. In: Giacobini E, Becker R, eds. Alzheimer Disease: Therapeutic Strategies. Proceedings of the Third International Springfield Alzheimer Symposium. Boston: Birkhauser Boston Inc; 1994."},{"key":"key-10.17116\/jnevro2019119041115-28","doi-asserted-by":"crossref","unstructured":"Seo MY, Lee SM. Protective effect of low dose of ascorbic acid on hepatobiliary function in hepatic ischemia\/reperfusion in rats. Journal of Hepatology. 2002;36(1):72-77.","DOI":"10.1016\/S0168-8278(01)00236-7"},{"key":"key-10.17116\/jnevro2019119041115-29","unstructured":"Vozmozhnye mekhanizmy dejstviya membranoaktivnyh veshchestv s antioksidantnymi svojstvami v ehkstremal'nyh situaciyah. V kn.: Kletochnye mekhanizmy realizacii farmakologichekogo ehffekta. Pod red. Seredenina S.B. M. 1990. (In Russ.)"},{"key":"key-10.17116\/jnevro2019119041115-30","unstructured":"Voronina TA, Seredenin SB. Analysis of the mechanism of psychotropic action of 3-hydroxypyridine derivative. Annali dell'Istituto Superiore di Sanita. 1988;24(3):461-466."},{"key":"key-10.17116\/jnevro2019119041115-31","unstructured":"Voronina TA, Smirnov LD, Dyumaev KM. Vliyanie membranomodulyatora iz klassa 3-oksipiridina na farmakologicheskuyu aktivnost' psihotropnyh preparatov. Bulletin of Experimental Biology and Medicine. 1985;XCIX(5):519-522. (In Russ.)"},{"key":"key-10.17116\/jnevro2019119041115-32","unstructured":"Voronina TA, Kutepova OA, Zolotov NN. Vliyanie antioksidantov iz klassa 3-oksipiridina na vyzvannoe ehtanolom narushenie obucheniya u myshej i nakoplenie lipofuscina. Bulletin of Experimental Biology and Medicine. 1989;3:314-316. (In Russ.)"},{"key":"key-10.17116\/jnevro2019119041115-33","unstructured":"Smirnov LD, Voronina TA, Dyumaev KM, Rudenko GM, Morozov GV. Protivoalkogol'noe sredstvo. Patent SSSR 1777878\/30.11.1992. Accessed February 20, 2019. (In Russ.) http:\/\/patents.su\/2-1777878-protivoalkogolnoe-sredstvo.html"},{"key":"key-10.17116\/jnevro2019119041115-34","unstructured":"Insul't. Rukovodstvo dlya vrachej. Pod red. Stahovskoj L.V., Kotova S.V. M.: OOO 'Medicinskoe informacionnoe agentstvo'; 2018. (In Russ.)"},{"key":"key-10.17116\/jnevro2019119041115-35","unstructured":"Insul't: sovremennye tekhnologii diagnostiki i lecheniya. Rukovodstvo dlya vrachej. Pod red. Piradova M.A., Tanashyan M.M., Maksimovoj M.Yu. M.: MEDpress-inform; 2018. (In Russ.)"},{"key":"key-10.17116\/jnevro2019119041115-36","unstructured":"Seregin VI. Primenenie Gliatilina i Meksidola v intensivnoj terapii tyazhelogo ostrogo ishemicheskogo insul'ta. Farmateka. 2006; 120(5):24. (In Russ.)"},{"key":"key-10.17116\/jnevro2019119041115-37","unstructured":"Skvorcova VI. Lechenie ostrogo ishemicheskogo insul'ta. Lechashchij vrach. 2004;7. Accessed February 20, 2019. (In Russ.) https:\/\/www.lvrach.ru\/2004\/07\/4531538\/"},{"key":"key-10.17116\/jnevro2019119041115-38","unstructured":"Isajkin AI, Chernyshova EA, Yahno NN. Primenenie nejroprotektivnoj terapii pri insul'tah i cherepno-mozgovoj travme. Trudnyj pacient. 2012;10(11):18-21. Accessed February 20, 2019. (In Russ.) http:\/\/t-pacient.ru\/articles\/217\/"},{"key":"key-10.17116\/jnevro2019119041115-39","unstructured":"Gusev EI, Skvorcova VI. Ishemiya golovnogo mozga. M.: Medicina; 2001. (In Russ.)"},{"key":"key-10.17116\/jnevro2019119041115-40","unstructured":"Vereshchagin NV, Piradov MA, Suslina ZA. Insul't. Principy diagnostiki, lecheniya i profilaktiki. Kratkoe rukovodstvo dlya vrachej. M.: Intermedika; 2002. (In Russ.)"},{"key":"key-10.17116\/jnevro2019119041115-41","unstructured":"Chefranova ZhYu, Makotrova TA, Udachin VA, Koledintseva EV. Efficacy of mexidol in the combination with thrombolytic therapy in patients with ischemic stroke. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2012;112(4):49-52. (In Russ.)"},{"key":"key-10.17116\/jnevro2019119041115-42","doi-asserted-by":"crossref","unstructured":"Knni KS, Dyomin TV, Adeeva LB. Effect of mexidol on the efficiency of intravenous thrombolytic therapy for ischemic stroke during the therapeutic window. Nevrologi\u00e2, Nejropsihiatri\u00e2, Psihosomatika. 2018;10(3):86-90. (In Russ.)","DOI":"10.14412\/2074-2711-2018-3-86-90"},{"key":"key-10.17116\/jnevro2019119041115-43","unstructured":"Skvortsova VI, Stakhovskaya LV, Nartzyssov YaR, Bodykhov MK, Kichuck IV, Gudkova YuV, Soldatenkova TD, Kondrasheva TT, Kalinina EV, Novichkova MD, Kerbikov OB. The randomized double-blind placebo-controlled study of efficacy and safety of mexidol in the complex therapy of ischemic stroke in the acute period. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova (App. 'Stroke'). 2006;18:47-54. (In Russ.)"},{"key":"key-10.17116\/jnevro2019119041115-44","unstructured":"Lutskii MA. An analysis of mexidol efficacy in the complex treatment of patients with ischemic stroke. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova (App. 'Stroke'). 2010;110(4-2):57-59. (In Russ.)"},{"key":"key-10.17116\/jnevro2019119041115-45","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro20171173255-65"},{"key":"key-10.17116\/jnevro2019119041115-46","unstructured":"Izhbul'dina GI. Changes in the hemostasis system and free-radical lipid oxidation in the acute stage of ischemic stroke in patients on neuroprotection treatment. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2012;112(3-2):31-37. (In Russ.)"},{"key":"key-10.17116\/jnevro2019119041115-47","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro20161165123-27"},{"key":"key-10.17116\/jnevro2019119041115-48","unstructured":"Shprakh VV, Matveeva IV, Spreis IF. Combined administration of amlodipine and mexidol in treatment early forms of chronic cerebral ischemia in coal mining workers. Byulleten' VSNC SO RAMN. 2006;51(5):207-210. (In Russ.)"},{"key":"key-10.17116\/jnevro2019119041115-49","unstructured":"Nechipurenko NI, Veres AI, Vasilevskaya LA, Pashkovskaya ID. Blood trace elements content and the condition of the dermal icrohaemodynamic in patients with dyscirculatory encephalopathy after the complex treatment with Mexidol. Nevrologiya i Nejrohirurgiya. Vostochnaya Evropa. 2011;3:98-108. (In Russ.)"},{"key":"key-10.17116\/jnevro2019119041115-50","unstructured":"Bulahova EYu. Ispol'zovanie preparata meksidol dlya optimizacii lecheniya arterial'noj gipertenzii u bol'nyh molodogo vozrasta. Bulletin of Experimental biology and Medicine. 2006;(suppl 1):101-103. (In Russ.)"},{"key":"key-10.17116\/jnevro2019119041115-51","unstructured":"Avakyan GG, Nerobkova LN, Oleynikova OM, Voronina TA, Avakyan GN, Gusev EI. Possibilities of application the prolonged form valproic acid and antioxidant in secondary-generalized seizures (clinical and experimental investigation). Epilepsia and Paroxyzmal Conditions. 2011;3(2):34-44. (In Russ.)"},{"key":"key-10.17116\/jnevro2019119041115-52","unstructured":"Litvinovich EF. Klinicheskaya i farmako-ehkonomicheskaya ehffektivnost' antioksidanta meksidola v kombinirovannoj patogeneticheskoj terapii bol'nyh s fokal'noj ehpilepsiej. Bulletin of Experimental Biology and Medicine. 2006;(suppl 1):45-47. (In Russ.)"},{"key":"key-10.17116\/jnevro2019119041115-53","unstructured":"Korotkov AG. Primenenie preparata meksidol v kompleksnom lechenii bol'nyh farmakorezistentnoj parcial'noj ehpilepsiej. Bulletin of Experimental Biology and Medicine. 2006;(suppl 1):34-36. (In Russ.)"},{"key":"key-10.17116\/jnevro2019119041115-54","unstructured":"Savenkov AA, Badalyan OL, Avakyan GN. Nootropics and antioxidants in the complex therapy of symptomatic posttraumatic epilepsy. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2013;116(6):26-34. (In Russ.)"},{"key":"key-10.17116\/jnevro2019119041115-55","unstructured":"Kurasov ES, Remizevich RS. The effect of mexidol in the combination with antidepressants on sleep disturbance in young patients with panic disorder. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2013;113(2):33-38. (In Russ.)"},{"key":"key-10.17116\/jnevro2019119041115-56","unstructured":"Nikol'skaya IN, Khromova OM, Irkhina IS, Goncharova MV, Orlova NA. Comparative evaluation of clinical efficacy and safety of mexidol in patients with acute coronary syndrome in addition to standart regimen of treatment. Kardiologiya i Serdechno-Sosudistaya Khirurgiya. 2013;6(3):37-42. (In Russ.)"},{"key":"key-10.17116\/jnevro2019119041115-57","doi-asserted-by":"crossref","unstructured":"Zhestovskikh SS, Petrova LV, Ametov AS. Prevention and treatment of diabetes mellitus: current status (review). Therapeutic Archive. 2007;79(10):46-50. (In Russ.)","DOI":"10.5005\/jp\/books\/10202_11"},{"key":"key-10.17116\/jnevro2019119041115-58","doi-asserted-by":"crossref","unstructured":"Lankin VZ, Lisina MO, Arzamastseva NE, Konovalova GG, Nedosugova LV, Kaminnyi AI, Tikhaze AK, Ageev FT, Kukharchuk VV, Belenkov YuN. Oxidative stress in atherosclerosis and diabetes. Bulletin of Experimental Biology and Medicine. 2005;140(7):48-51. (In Russ.)","DOI":"10.1007\/s10517-005-0406-z"},{"key":"key-10.17116\/jnevro2019119041115-59","unstructured":"Goryushkina OA, Vasilyeva EM. Antioxidant therapy in the correction of oxidative stress in the patients with coronary heart disease and type II diabetes. Journal of New Medical Technologies. 2013;(2):156. (In Russ.)"},{"key":"key-10.17116\/jnevro2019119041115-60","unstructured":"Mihin VP. Kardiocitoprotektory - novoe napravlenie klinicheskoj kardiologii. Arhiv Vnutrennej Mediciny. 2011;1:21-28. (In Russ.)"},{"key":"key-10.17116\/jnevro2019119041115-61","unstructured":"Zateyshchikov DA, Minushkina LO, Kudryashova OYU, Barinov VG, Tsimbalova TE, Nosenko EM, Sedov VP, Sidorenko BA. Functional state of endothelium in patients with hypertension and ischemic heart disease. Kardiologiia. 2000;40(2):14-17. (In Russ.)"},{"key":"key-10.17116\/jnevro2019119041115-62","doi-asserted-by":"publisher","DOI":"10.17116\/kardio201710138-41"},{"key":"key-10.17116\/jnevro2019119041115-63","unstructured":"Mihin VP, Smirnov LD, Sernov LN. Sredstvo dlya lecheniya nestabil'noj stenokardii i ostrogo infarkta miokarda. Patent RF na izobretenie #2168993\/11.05.2000. Byul. #17. Accessed February 20, 2019. (In Russ.) https:\/\/patents.google.com\/patent\/RU2168993C1\/ru"},{"key":"key-10.17116\/jnevro2019119041115-64","unstructured":"Volchegorskii IA, Tur EV, Solyannikova OV, Rykun VS, Sumina MS, Dmitrienko VN, Berdnikova EV. Effectiveness of 3-hydroxypyridine and succinic acid derivatives in complex treatment of primary open-angle glaucoma. Eksperimental'naia i Klinicheskaia Farmakologiia. 2012;75(7):20-26. (In Russ.)"},{"key":"key-10.17116\/jnevro2019119041115-65","unstructured":"Egorov EA, Davydova NG, Romanenko IA, Novikova ND. Mexidol in complex treatment of glaucoma. RMZh. Klinicheskaya Oftal'mologiya. 2011;12(3):107-110. (In Russ.)"},{"key":"key-10.17116\/jnevro2019119041115-66","unstructured":"Savlukov AI, Kildebekova RN, Farshatov RS. Coorection of lipid peroxydation and antioxydant protective system by mexidol and glycine in patiens with acute ethanol intoxication. Saratov Journal of Medical Scientifc Research. 2009;5(4):507-510. (In Russ.)"},{"key":"key-10.17116\/jnevro2019119041115-67","unstructured":"Pharshatov RS, Haphysov NH, Kildibekova RN, Savlukov AI. Cognitive functions imapirement in patients with acute alcoholintoxication and their treatment with antioxydant drugs. Fundamental Research. 2012;7:208-210. (In Russ.)"}],"container-title":["Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T05:34:20Z","timestamp":1559540060000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.mediasphera.ru\/issues\/zhurnal-nevrologii-i-psikhiatrii-im-s-s-korsakova\/2019\/4\/downloads\/ru\/1199772982019041115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"alternative-id":["jnevro2019119041115"],"URL":"https:\/\/doi.org\/10.17116\/jnevro2019119041115","relation":{},"ISSN":["1997-7298"],"issn-type":[{"value":"1997-7298","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}